Research Progress on the Effects and Mechanisms of L-carnitine on Improving Metabolic Syndrome

被引：0
|
作者：
Sun C. [1 ]
Zhang Y. [1 ]
Chen Q. [2 ]
Li J. [3 ]
Li T. [3 ]
Wei Y. [1 ]
Gao X. [1 ]
机构：
[1] College of Life Sciences, Qingdao University, Qingdao
[2] College of Food Science and Engineering, Qingdao Agricultural University, Qingdao
[3] Anqiu Huatao Food Co., Ltd, Weifang
来源：
Science and Technology of Food Industry | 2023年 / 44卷 / 01期
关键词：
improvement effects; L-carnitine; mechanisms; metabolic syndrome; trimethylamine N-oxide;
D O I：
10.13386/j.issn1002-0306.2022030263
中图分类号：
学科分类号：
摘要：
Metabolic syndrome is a group of clinical syndromes, including obesity, dyslipidemia, hypertension, hyperuricemia, hyperglycemia and insulin resistance. These syndromes are critical risk factors for cardiovascular disease and diabetes. Recent studies indicate that L-carnitine exhibits potential improvement effects on metabolic syndrome. In the current study, the sources of L-carnitine for human and the effects and mechanisms of L-carnitine on the major components of metabolic syndrome, such as obesity and dyslipidemia, etc were summarized. The potential health risk of L-carnitine by serving as a dietary precursor for trimethylamine N-oxide was also discussed. This study provides theoretical basis and references for the treatment of metabolic syndrome and the rational dietary supplement and utilization of L-carnitine. © 2023, Editorial Department of Science and Technology of Food Science. All rights reserved.
引用
收藏
页码：475 / 484
页数：9
相关论文
共 97 条
  • [1] LEMIEUX I, DESPRES J., Metabolic syndrome: Past, present and future[J], Nutrients, 12, 11, pp. 3501-3507, (2020)
  • [2] SAKLAYEN M G., The global epidemic of the metabolic syndrome[J], Current Hypertension Reports, 20, 2, (2018)
  • [3] Report on cardiovascular health and diseases in China 2019: An updated summary[J], Prevention and Treatment of Cardio-Cerebral-Vascular Disease, 20, 5, pp. 437-450, (2020)
  • [4] CHOI M J, PARK S M, LEE M S., L-carnitine's effect on the biomarkers of metabolic syndrome: A systematic review and metaanalysis of randomized controlled trials[J], Nutrients, 12, 9, (2020)
  • [5] HU X Y, WANG H J., Study advance on the correlation between the metabolism of L-carnitine through intestinal microorganisms and the risk of atherosclerosis[J], Molecular Cardiology of China, 20, 3, (2020)
  • [6] REUTER S E, EVANS A M., Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects[J], Clinical Pharmacokinetics, 51, 9, (2012)
  • [7] ADEVA-ANDANY M M, CALVO-CASTRO I, FERNANDEZ FERNANDEZ C, Et al., Significance of L-carnitine for human health[J], IUBMB Life, 69, 8, pp. 578-594, (2017)
  • [8] DEMARQUOY J, GEORGES B, RIGAULT C, Et al., Radioisotopic determination of L-carnitine content in foods commonly eaten in western countries[J], Food Chemistry, 86, 1, pp. 137-142, (2003)
  • [9] OZOGUL Y, KULEY B E, OZOGUL F, Et al., L-carnitine contents in seafoods commonly eaten in middle eastern countries[J], Journal of Food Biochemistry, 37, 6, pp. 702-707, (2012)
  • [10] KOETH R A, LAM-GALVEZ B R, KIRSOP J, Et al., L-carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans[J], The Journal of Clinical Investigation, 129, 1, pp. 373-387, (2019)
12345678910